Assessing the readability of ClinicalTrials.gov
- PMID: 26269536
- PMCID: PMC5009924
- DOI: 10.1093/jamia/ocv062
Assessing the readability of ClinicalTrials.gov
Abstract
Objective: ClinicalTrials.gov serves critical functions of disseminating trial information to the public and helping the trials recruit participants. This study assessed the readability of trial descriptions at ClinicalTrials.gov using multiple quantitative measures.
Materials and methods: The analysis included all 165,988 trials registered at ClinicalTrials.gov as of April 30, 2014. To obtain benchmarks, the authors also analyzed 2 other medical corpora: (1) all 955 Health Topics articles from MedlinePlus and (2) a random sample of 100,000 clinician notes retrieved from an electronic health records system intended for conveying internal communication among medical professionals. The authors characterized each of the corpora using 4 surface metrics, and then applied 5 different scoring algorithms to assess their readability. The authors hypothesized that clinician notes would be most difficult to read, followed by trial descriptions and MedlinePlus Health Topics articles.
Results: Trial descriptions have the longest average sentence length (26.1 words) across all corpora; 65% of their words used are not covered by a basic medical English dictionary. In comparison, average sentence length of MedlinePlus Health Topics articles is 61% shorter, vocabulary size is 95% smaller, and dictionary coverage is 46% higher. All 5 scoring algorithms consistently rated CliniclTrials.gov trial descriptions the most difficult corpus to read, even harder than clinician notes. On average, it requires 18 years of education to properly understand these trial descriptions according to the results generated by the readability assessment algorithms.
Discussion and conclusion: Trial descriptions at CliniclTrials.gov are extremely difficult to read. Significant work is warranted to improve their readability in order to achieve CliniclTrials.gov's goal of facilitating information dissemination and subject recruitment.
Keywords: CliniclTrials.gov; clinical trial; comprehension; electronic health records; natural language processing; readability.
Published by Oxford University Press on behalf of the American Medical Informatics Association 2015. This work is written by US Government employees and is in the public domain in the US.
Figures





References
-
- Food and Drug Administration Amendments Act of 2007 (FDAAA), Section 801. 2007; PUBLIC LAW 110–85—SEPT. 27. http://clinicaltrials.gov/ct2/manage-recs/fdaaa; accessed November 15, 2014.
-
- Angelis CD, Drazen JM, Frizelle FA, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med. 2004;351(12):1250–1251. - PubMed
-
- Trends, Charts, and Maps. 2014. http://www.clinicaltrials.gov/ct2/resources/trends. Accessed November 15, 2014.
-
- Background of ClincialTrials.gov. http://www.clinicaltrials.gov/ct2/about-site/background. Accessed November 15, 2014.
-
- Historical perspective on the development of ClinicalTrials.gov, and an overview of FDA’s role in supporting the success of the database, and accessibility to clinical trials information by the public. http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/Participa.... Accessed November 15, 2014.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous